A recent study explodes the myth that the risk of addiction to prescription opioids exists only among patients abusing their opioids. Until recently, the National Survey on Drug Use and Health ...

How to tell if someone is overdosing on fentanyl and other opioids Where to get free Narcan, needles and other help for drug users Relapse. Overdose. Saving lives: How a Detroit addict and mom of ...

Endo's slide into bankruptcy follows in the footsteps of Purdue Pharma – which filed in 2019 but is still negotiating opioid settlement and corporate restructuring terms – as well as ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...

That included an internet and telephone service that connected opioid users to doctors known to be high opioid prescribers, it adds. As a result, there was “false and misleading safety ...

New York State Senator Pete Harckham, in partnership with Westchester County Legislator Erika Pierce, hosted a naloxone training on Wednesday, Jan. 29, giving 25 people, including first responders and ...

Copyright 2025 The Associated Press. All Rights Reserved. U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and ...

The Food and Drug Administration (FDA) on Thursday approved Journavx (suzetrigine), a new non-opioid painkiller that promises to be nonaddictive. Journavx is approved to treat moderate-to-severe acute ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The US Food and ...

Journavx (suzetrigine), a non-opioid pill for moderate-to-severe acute pain, has just received FDA approval. It’s the first drug in a new family of medicines that block pain signals before they ...

"The Social Network," David Fincher's 2010 masterpiece about Mark Zuckerberg, may explain why the Meta boss seems to answer to Donald Trump.